23.01.2017 16:45:00

Johnson & Johnson to Participate in the Leerink Partners 6th Annual Global Healthcare Conference

NEW BRUNSWICK, N.J., Jan. 23, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, Feb. 16, at Lotte New York Palace, NY.  Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-leerink-partners-6th-annual-global-healthcare-conference-300394721.html

SOURCE Johnson & Johnson

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,14 -0,09% Johnson & Johnson